Antiviral activity of geneticin against dengue virus

Antiviral Research

Volumn 83, Issue 1, 2009, Pages 21-27

  Zhang, Xianchao G ^a   Mason, Peter W ^b   Dubovi, Edward J ^c   Xu, Xiaodong ^a   Bourne, Nigel ^b   Renshaw, Randall W ^c   Block, Timothy M ^a   Birk, Alexander V ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

Aminoglycosides; Antiviral; Dengue; Flaviviruses; Geneticin

Indexed keywords

ANTIBIOTIC G 418; GENTAMICIN; KANAMYCIN; NEOMYCIN; PAROMOMYCIN; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN BHK; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DENGUE; DENGUE VIRUS; DRUG SELECTIVITY; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS LOAD; VIRUS PLAQUE; YELLOW FEVER FLAVIVIRUS;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CRICETINAE; CYTOPATHOGENIC EFFECT, VIRAL; DENGUE VIRUS; GENTAMICINS; INHIBITORY CONCENTRATION 50; PLAQUE ASSAY; YELLOW FEVER VIRUS;

BOVINE VIRAL DIARRHEA VIRUS 1; DENGUE VIRUS; FLAVIVIRIDAE; YELLOW FEVER VIRUS;

EID: 67349161336     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.02.204     Document Type: Article

References (40)

1. Anon. Dengue/dengue haemorrhagic fever. Wkly. Epidemiol. Rec. 75 (2000) 193-196
2. Benveniste R., and Davies J. Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups. Antimicrob. Agents Chemother. 4 (1973) 402-409
3. Borovinskaya M.A., Pai R.D., Zhang W., Schuwirth B.S., Holton J.M., Hirokawa G., Kaji H., Kaji A., and Cate J.H. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nat. Struct. Mol. Biol. 14 (2007) 727-732
4. Borovinskaya M.A., Shoji S., Holton J.M., Fredrick K., and Cate J.H. A steric block in translation caused by the antibiotic spectinomycin. ACS Chem. Biol. 2 (2007) 545-552
5. Birk A., Dubovi E.J., Zhang X., and Szeto H.H. Antiviral activity of geneticin against bovine viral diarrhea virus. Antivir. Chem. Chemother. 19 (2008) 33-40
6. Cabanas M.J., Vázquez D., and Modolell J. Inhibition of ribosomal translocation by aminoglycoside antibiotics. Biochem. Biophys. Res. Commun. 83 (1978) 991-997
7. Chia J.S., Wu H.L., Wang H.W., Chen D.S., and Chen P.J. Inhibition of hepatitis delta virus genomic ribozyme self-cleavage by aminoglycosides. J. Biomed. Sci. 4 (1997) 208-216
8. Collett M.S., Anderson D.K., and Retzel E. Comparisons of the pestivirus bovine viral diarrhoea virus with members of the flaviviridae. J. Gen. Virol. 69 (1988) 2637-2643
9. Danielson K.G., Knepper J.E., Kittrell F.S., Butel J.S., Medina D., and Durban E.M. Clonal populations of the mouse mammary cell line, COMMA-D, which retain capability of morphogenesis in vivo. In Vitro Cell Dev. Biol. 25 (1989) 535-543
10. Eustice D.C., and Wilhelm J.M. Mechanisms of action of aminoglycoside antibiotics in eukaryotic protein synthesis. Antimicrob. Agents Chemother. 26 (1984) 53-60
11. Garcin D., Massé T., Madjar J.J., and Jacquemont B. Herpes simplex virus type-1 immediate-early gene expression and shut off of host protein synthesis are inhibited in neomycin-treated human epidermoid carcinoma 2 cells. Eur. J. Biochem. 194 (1990) 279-286
12. Gatti P.J., Choi B., Haislip A.M., Fermin C.D., and Garry R.F. Inhibition of HIV type 1 production by hygromycin B. AIDS Res. Hum. Retroviruses 14 (1998) 885-892
13. Ghendon Yu.Z., and Klimov A.I. Effects of edeine, hygromycin B and alpha-Sarcin on influenza virus reproduction. Acta Virol. 25 (1981) 129-137
14. Gu B., Mason P., Wang L., Norton P., Bourne N., Moriarty R., Mehta A., Despande M., Shah R., and Block T. Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus. Antivir. Chem. Chemother. 18 (2007) 49-59
15. Herold B.C., and Spear P.G. Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry. Virology 203 (1994) 166-171
16. Herold B.C., Visalli R.J., Susmarski N., Brandt C.R., and Spear P.G. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J. Gen. Virol. 75 (1994) 1211-1222
17. Hung S.L., Wang Y.H., Chen H.W., Lee P.L., and Chen Y.T. Analysis of herpes simplex virus entering into cells of oral origin. Virus Res. 86 (2002) 59-69
18. Konno T., Takahashi T., Kurita D., Muto A., and Himeno H. A minimum structure of aminoglycosides that causes an initiation shift of trans-translation. Nucleic Acids Res. 32 (2004) 4119-4126
19. Kurane I., Rothman A.L., Livingston P.G., Green S., Gagnon S.J., Janus J., Innis B.L., Nimmannitya S., Nisalak A., and Ennis F.A. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. Suppl. 9 (1994) 59-64
20. Lacal J.C., and Carrasco L. Antiviral effects of hygromycin B, a translation inhibitor nonpermeant to uninfected cells. Antimicrob. Agents Chemother. 24 (1983) 273-275
21. Lacal J.C., Vázquez D., Fernandez-Sousa J.M., and Carrasco L. Antibiotics that specifically block translation in virus-infected cells. J. Antibiot. (Tokyo) 33 (1980) 441-446
22. Lai C.H., Chun H.H., Nahas S.A., Mitui M., Gamo K.M., Du L., and Gatti R.A. Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15676-15681
23. Langeland N., Haarr L., and Holmsen H. Evidence that neomycin inhibits HSV 1 infection of BHK cells. Biochem. Biophys. Res. Commun. 141 (1986) 198-203
24. Langeland N., Holmsen H., Lillehaug J.R., and Haarr L. Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor. J. Virol. 61 (1987) 3388-3393
25. Litovchick A., Evdokimov A.G., and Lapidot A. Aminoglycoside-arginine conjugates that bind TAR RNA: synthesis, characterization, and antiviral activity. Biochemistry 39 (2000) 2838-2852
26. Litovchick A., Lapidot A., Eisenstein M., Kalinkovich A., and Borkow G. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities. Biochemistry 40 (2001) 15612-15623
27. Lobert P.E., Hober D., Delannoy A.S., and Wattré P. Evidence that neomycin inhibits human cytomegalovirus infection of fibroblasts. Arch. Virol. 141 (1996) 1453-1462
28. Macintyre G., Curry B., Wong F., and Anderson R. Hygromycin B therapy of a murine coronaviral hepatitis. Antimicrob. Agents Chemother. 35 (1991) 2125-2127
29. Macintyre G., Woods D.E., and Anderson R. Hygromycin B inhibits synthesis of murine coronavirus RNA. Antimicrob. Agents Chemother. 35 (1991) 2630-2633
30. Mazzio E.A., and Soliman K.F. Glioma cell antioxidant capacity relative to reactive oxygen species produced by dopamine. J. Appl. Toxicol. 24 (2004) 99-106
31. Paeshuyse J., Leyssen P., Mabery E., Boddeker N., Vrancken R., Froeyen M., Ansari I.H., Dutartre H., Rozenski J., Gil L.H., Letellier C., Lanford R., Canard B., Koenen F., Kerkhofs P., Donis R.O., Herdewijn P., Watson J., De Clercq E., Puerstinger G., and Neyts J. A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase. J. Virol. 80 (2006) 149-160
32. Raviprakash K., Wang D., Ewing D., Holman D.H., Block K., Woraratanadharm J., Chen L., Hayes C., Dong J.Y., and Porter K. A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus. J. Virol. 82 (2008) 6927-6934
33. Rogers J., Chang A.H., von Ahsen U., Schroeder R., and Davies J. Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics. J. Mol. Biol. 259 (1996) 916-925
34. Santerre R.F., Allen N.E., Hobbs Jr. J.N., Rao R.N., and Schmidt R.J. Expression of prokaryotic genes for hygromycin B and G418 resistance as dominant-selection markers in mouse L cells. Gene 30 (1984) 147-156
35. Tassew N., and Thompson M. Binding affinity and inhibitory potency of neomycin and streptomycin on the Tat peptide interaction with HIV-1 TAR RNA detected by on-line acoustic wave sensor. Org. Biomol. Chem. 1 (2003) 3268-3270
36. Thompson P.R., Schwartzenhauer J., Hughes D.W., Berghuis A.M., and Wright G.D. The COOH terminus of aminoglycoside phosphotransferase (3′)-IIIa is critical for antibiotic recognition and resistance. J. Biol. Chem. 274 (1999) 30697-30706
37. Vicens Q., and Westhof E. Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide. J. Mol. Biol. 326 (2003) 1175-1188
38. Wang W.K., Sung T.L., Tsai Y.C., Kao C.L., Chang S.M., and King C.C. Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcription-real-time PCR assay. J. Clin. Microbiol. 40 (2002) 4472-4478
39. Yang C., Feng J., Song W., Wang J., Tsai B., Zhang Y., Scaringe W.A., Hill K.A., Margaritis P., High K.A., and Sommer S.S. A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 15394-15399
40. Zapp M.L., Stern S., and Green M.R. Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 74 (1993) 969-978